A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment

por Wu, Chiao-Chieh, Chiang, Chen-Yi, Liu, Shih-Jen, Chen, Hsin-Wei
Publicado 2021

Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment

por Yan, Wan-Lun, Wu, Chiao-Chieh, Shen, Kuan-Yin, Liu, Shih-Jen
Publicado 2021

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population

por Wu, Chiao-Chieh, Liu, Shih-Jen, Chen, Hsin-Wei, Shen, Kuan-Yin, Leng, Chih-Hsiang
Publicado 2016

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity

por Chiang, Chen-Yi, Chen, Yi-Jyun, Wu, Chiao-Chieh, Liu, Shih-Jen, Leng, Chih-Hsiang, Chen, Hsin-Wei
Publicado 2018

Delivery of Antigen to CD8(+) Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity

por Chiang, Chen-Yi, Wu, Chiao-Chieh, Chen, Yi-Jyun, Liu, Shih-Jen, Leng, Chih-Hsiang, Chen, Hsin-Wei
Publicado 2019

Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipop...

por Chang, Li-Sheng, Leng, Chih-Hsiang, Yeh, Yi-Chen, Wu, Chiao-Chieh, Chen, Hsin-Wei, Huang, Hai-Mei, Liu, Shih-Jen
Publicado 2014

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice

por Chen, Mei-Yu, Chai, Kit Man, Chiang, Chen-Yi, Wu, Chiao-Chieh, Yu, Guann-Yi, Liu, Shih-Jen, Chen, Hsin-Wei
Publicado 2020

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells

por Shen, Kuan-Yin, Liu, Hsin-Yu, Yan, Wan-Lun, Wu, Chiao-Chieh, Lee, Ming-Hui, Leng, Chih-Hsing, Liu, Shih-Jen
Publicado 2020

Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Systemic Antibody Responses and Broad T Cell Responses

por Hsieh, Ming-Shu, Hsu, Chia-Wei, Tu, Ling-Ling, Chai, Kit Man, Yu, Li-Lu, Wu, Chiao-Chieh, Chen, Mei-Yu, Chiang, Chen-Yi, Liu, Shih-Jen, Liao, Ching-Len, Chen, Hsin-Wei
Publicado 2021

Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types

por Hsieh, Ming-Shu, Chen, Mei-Yu, Hsu, Chia-Wei, Tsai, Yu-Wen, Chiu, Fang-Feng, Hsu, Cheng-Lung, Lin, Chang-Ling, Wu, Chiao-Chieh, Tu, Ling-Ling, Chiang, Chen-Yi, Liu, Shih-Jen, Liao, Ching-Len, Chen, Hsin-Wei
Publicado 2023